search
Back to results

The First Puncture Success Rate of a Novel Injeq IQ-Tip™ System in Pediatric Lumbar Punctures (IQ-LP-03)

Primary Purpose

Lumbar Puncture

Status
Completed
Phase
Not Applicable
Locations
Finland
Study Type
Interventional
Intervention
IQ-Tip(tm) system
Sponsored by
Injeq Ltd
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional other trial for Lumbar Puncture focused on measuring Spinal puncture, Lumbar puncture

Eligibility Criteria

18 Months - 18 Years (Child, Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Pediatric hemato-oncology patients whose diagnosis or treatment plan requires lumbar puncture to acquire a CSF sample or to inject drug or other substance
  • Written and signed informed consent before the procedure from the parent and/or patient depending on the age of the patient

Exclusion Criteria:

  • Parents and/or patient refusal to participate or parents and/or patient unable to give informed consent
  • Any contraindications to a lumbar puncture. Contraindications include skin infection around the puncture area, unstable hemodynamics, bleeding tendency and increased intracranial pressure

Sites / Locations

  • Helsinki University Hospital, New Children's Hospital
  • Tampere University Hospital
  • Turku University Hospital

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

IQ-Tip

Arm Description

At most four lumbar punctures with Injeq IQ-Tip(tm) system per participant

Outcomes

Primary Outcome Measures

The First Puncture Success Rate
Each individual lumbar puncture procedure is assessed as either 'first puncture success' or '-failure'. Success rate = Successes / All procedures Definition of the first puncture success: Only one skin puncture with the needle is allowed; Multiple stylet removals and reinsertions are allowed; Multiple needle reorientations are allowed as long as needle tip remains inside the skin; Physician must be able obtain a cerebrospinal fluid (CSF) sample that is sent to a laboratory analysis or to inject the intended medication to the patient's subarachnoid space; and Physician conducting the puncture remains the same during the procedure
Rate of Serious Adverse Events
Total number of serious adverse events caused by the device. Serious adverse event in probable or causal relationship to the investigational device exposure

Secondary Outcome Measures

Percentage of Procedures With Post-dural Puncture Headache (PDPH)
PDPH defined as headache that: worsens in sitting or standing position eases when lying down occurs within 7 days after the lumbar puncture procedure Possible symptoms are recording using a diary filled by the patient or parents and verified by the study nurse.
Percentage of CSF Samples With Greater or Equal to 10 Erythrocytes / mm^3
Erythrocyte (red blood cell) count according to laboratory analysis in units of 10^6/liter or 1/mm3
Percentage of Procedures With Other Complications or Adverse Events
E.g. PDPH or backache Possible symptoms are recorded using a diary filled by the patient or parents and verified by the study nurse. Diary is an open questionaire that is intended for recording any possible complication. Possible complications are not considered as pre-determined outcome measures, with the exception of Outcome #3 (rate of PDPH) Four-week follow up conducted by the study nurse from the hospital registers
Aggregate Sensitivity of CSF Detection
The CSF detection performance of the investigational device is assessed by the physician. Each individual lumbar puncture procedure is classified as either 'True Positive CSF detection (TP)', 'False Negative CSF detection (FN)' or 'Procedure failed (Fail)' by the investigator. The aggregate sensitivity = Number of TPs / Total number of procedures
Aggregate False Detection Rate of CSF Detection
Each individual lumbar puncture procedure is classified as either 'One or more False Positive CSF detections (FP)' or 'No False Positive CSF detections (TN)'. The aggregate false detection rate = Number of FPs / Total number of procedures
Number of Required Attempts Per Successful Lumbar Puncture Procedure
In line with definition of 'the first puncture success rate', attempt is defined as: any new penetration of skin is considered a new attempt. Lumbar puncture is considered successful irrespective of the number of punctures if the CSF sample was eventually obtained and/or the injection of medicine could be performed
Number of Failed Lumbar Puncture Procedures
Procedure is considered failed if physicians, even after multiple attempts, conclude that the lumbar puncture cannot be completed with available personnel or equipment due to any reason

Full Information

First Posted
August 23, 2019
Last Updated
June 12, 2023
Sponsor
Injeq Ltd
search

1. Study Identification

Unique Protocol Identification Number
NCT04070144
Brief Title
The First Puncture Success Rate of a Novel Injeq IQ-Tip™ System in Pediatric Lumbar Punctures
Acronym
IQ-LP-03
Official Title
The First Puncture Success Rate of a Novel Injeq IQ-Tip™ System in Pediatric Lumbar Punctures
Study Type
Interventional

2. Study Status

Record Verification Date
June 2023
Overall Recruitment Status
Completed
Study Start Date
November 8, 2019 (Actual)
Primary Completion Date
August 6, 2020 (Actual)
Study Completion Date
October 2, 2020 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Injeq Ltd

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
The investigation aims to demonstrate the first puncture success rate, as proxy of clinical benefit and clinical performance, of bioimpedance spectroscopy based spinal needle guidance method among pediatric hemato-oncology patients requiring lumbar punctures.
Detailed Description
The primary purpose of the investigation is to demonstrate the claimed clinical benefit and safety of Injeq IQ-Tip™ system. IQ-Tip™ is similar to common spinal needles with a custom-made stylet that enables the real-time bioimpedance measurement at the tip of the needle. The needle is connected to the analyzer device, which provides real-time CSF detection during lumbar puncture from the very tip of the needle and by these means assists conducting the medical procedure. The investigation aims to demonstrate the first puncture success rate, as proxy of clinical benefit and clinical performance, of bioimpedance spectroscopy based spinal needle guidance method among pediatric hemato-oncology patients requiring lumbar punctures. The investigation is conducted in the pediatric hematology and oncology units of three Finnish university hospitals

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Lumbar Puncture
Keywords
Spinal puncture, Lumbar puncture

7. Study Design

Primary Purpose
Other
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
50 (Actual)

8. Arms, Groups, and Interventions

Arm Title
IQ-Tip
Arm Type
Experimental
Arm Description
At most four lumbar punctures with Injeq IQ-Tip(tm) system per participant
Intervention Type
Device
Intervention Name(s)
IQ-Tip(tm) system
Intervention Description
Physician performs therapeutic or diagnostic lumbar puncture using Injeq IQ-Tip(tm) system
Primary Outcome Measure Information:
Title
The First Puncture Success Rate
Description
Each individual lumbar puncture procedure is assessed as either 'first puncture success' or '-failure'. Success rate = Successes / All procedures Definition of the first puncture success: Only one skin puncture with the needle is allowed; Multiple stylet removals and reinsertions are allowed; Multiple needle reorientations are allowed as long as needle tip remains inside the skin; Physician must be able obtain a cerebrospinal fluid (CSF) sample that is sent to a laboratory analysis or to inject the intended medication to the patient's subarachnoid space; and Physician conducting the puncture remains the same during the procedure
Time Frame
The assessment immediately following each lumbar puncture procedure
Title
Rate of Serious Adverse Events
Description
Total number of serious adverse events caused by the device. Serious adverse event in probable or causal relationship to the investigational device exposure
Time Frame
The assessment during four-week follow-up after each lumbar puncture procedure
Secondary Outcome Measure Information:
Title
Percentage of Procedures With Post-dural Puncture Headache (PDPH)
Description
PDPH defined as headache that: worsens in sitting or standing position eases when lying down occurs within 7 days after the lumbar puncture procedure Possible symptoms are recording using a diary filled by the patient or parents and verified by the study nurse.
Time Frame
The assessment during 7-day follow-up after each lumbar puncture procedure
Title
Percentage of CSF Samples With Greater or Equal to 10 Erythrocytes / mm^3
Description
Erythrocyte (red blood cell) count according to laboratory analysis in units of 10^6/liter or 1/mm3
Time Frame
The laboratory analysis within 3 hours of the lumbar puncture
Title
Percentage of Procedures With Other Complications or Adverse Events
Description
E.g. PDPH or backache Possible symptoms are recorded using a diary filled by the patient or parents and verified by the study nurse. Diary is an open questionaire that is intended for recording any possible complication. Possible complications are not considered as pre-determined outcome measures, with the exception of Outcome #3 (rate of PDPH) Four-week follow up conducted by the study nurse from the hospital registers
Time Frame
The assessment during 7-day and four-week follow ups
Title
Aggregate Sensitivity of CSF Detection
Description
The CSF detection performance of the investigational device is assessed by the physician. Each individual lumbar puncture procedure is classified as either 'True Positive CSF detection (TP)', 'False Negative CSF detection (FN)' or 'Procedure failed (Fail)' by the investigator. The aggregate sensitivity = Number of TPs / Total number of procedures
Time Frame
The assessment immediately following each lumbar puncture procedure
Title
Aggregate False Detection Rate of CSF Detection
Description
Each individual lumbar puncture procedure is classified as either 'One or more False Positive CSF detections (FP)' or 'No False Positive CSF detections (TN)'. The aggregate false detection rate = Number of FPs / Total number of procedures
Time Frame
The assessment immediately following each lumbar puncture procedure
Title
Number of Required Attempts Per Successful Lumbar Puncture Procedure
Description
In line with definition of 'the first puncture success rate', attempt is defined as: any new penetration of skin is considered a new attempt. Lumbar puncture is considered successful irrespective of the number of punctures if the CSF sample was eventually obtained and/or the injection of medicine could be performed
Time Frame
The assessment immediately following each lumbar puncture procedure
Title
Number of Failed Lumbar Puncture Procedures
Description
Procedure is considered failed if physicians, even after multiple attempts, conclude that the lumbar puncture cannot be completed with available personnel or equipment due to any reason
Time Frame
The assessment immediately following each lumbar puncture procedure

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Months
Maximum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Pediatric hemato-oncology patients whose diagnosis or treatment plan requires lumbar puncture to acquire a CSF sample or to inject drug or other substance Written and signed informed consent before the procedure from the parent and/or patient depending on the age of the patient Exclusion Criteria: Parents and/or patient refusal to participate or parents and/or patient unable to give informed consent Any contraindications to a lumbar puncture. Contraindications include skin infection around the puncture area, unstable hemodynamics, bleeding tendency and increased intracranial pressure
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Sauli Palmu, PhD MD
Organizational Affiliation
Tampere University Hospital
Official's Role
Principal Investigator
Facility Information:
Facility Name
Helsinki University Hospital, New Children's Hospital
City
Helsinki
Country
Finland
Facility Name
Tampere University Hospital
City
Tampere
Country
Finland
Facility Name
Turku University Hospital
City
Turku
Country
Finland

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

The First Puncture Success Rate of a Novel Injeq IQ-Tip™ System in Pediatric Lumbar Punctures

We'll reach out to this number within 24 hrs